ALKERMES | ALKS - PE Price to Earnings

Stock Price
37.48
Daily Change
-0.88 -2.29%
Monthly
11.00%
Yearly
19.29%
Q2 Forecast
33.96

ALKERMES reported 39.33 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
ALKERMES 39.33 19.8 Mar/2026
Amgen 19.84 5.47 Mar/2026
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 24.53 0.91 Mar/2026
Malin Corporation 11.81 0.72 Jun/2023
Merck 16.52 2.6 Mar/2026
Neurocrine Biosciences 28.09 807.38 Mar/2026
Otsuka Holdings 14.31 2.24 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 9.32 5.16 Mar/2026
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026